AGT and atrial fibrillation: In the Optimal Therapy In Myocardial infarction with the Angiotensin II Antagonist Losartan trial (OPTIMAAL) trial the cumulative incidence of new-onset AF was 7.2% in the study population of patients with MI and either clinical signs of heart failure or left ventricular dysfunction (LVEF≤40%) [1].